306 related articles for article (PubMed ID: 8512434)
1. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
[TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
3. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.
Grodstein F; Stampfer MJ; Manson JE; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1996 Aug; 335(7):453-61. PubMed ID: 8672166
[TBL] [Abstract][Full Text] [Related]
5. Noncontraceptive estrogen use and cardiovascular disease.
Bush TL; Barrett-Connor E
Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
[TBL] [Abstract][Full Text] [Related]
6. [Hormone replacement therapy and cardiovascular risk].
Maffei S; De Caterina R
G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
[TBL] [Abstract][Full Text] [Related]
7. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
Burkman RT
Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease in women: implications of hormone replacement therapy.
Sarrel PM
Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal estrogen and cardiovascular disease.
Stampfer MJ; Grodstein F; Bechtel S
Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
[TBL] [Abstract][Full Text] [Related]
10. Hormones and cardiovascular health in women.
ESHRE Capri Workshop Group
Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
[TBL] [Abstract][Full Text] [Related]
11. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and cardiovascular disease in women.
Stefanick ML
Nutr Metab Cardiovasc Dis; 2010 Jul; 20(6):451-8. PubMed ID: 20554177
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
16. The controversy over estrogen replacement therapy: an update on clinical trials.
Gnatuk CL
Curr Womens Health Rep; 2002 Apr; 2(2):89-94. PubMed ID: 12116607
[TBL] [Abstract][Full Text] [Related]
17. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
Ribot C; Trémollieres F
Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and cardiovascular risk.
VandeKieft G
J Fam Pract; 1996 Nov; 43(5):437-8. PubMed ID: 8917138
[No Abstract] [Full Text] [Related]
19. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
20. The rationale for a wider range of progestogens.
Skouby SO
Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
